Tower Research Capital LLC (Trc) Clear Point Neuro, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 10,681 shares of CLPT stock, worth $119,734. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,681
Previous 1,574
578.59%
Holding current value
$119,734
Previous $10,000
470.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CLPT
# of Institutions
90Shares Held
7.04MCall Options Held
35KPut Options Held
22.8K-
Vanguard Group Inc Valley Forge, PA1.22MShares$13.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny465KShares$5.22 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA463KShares$5.19 Million0.49% of portfolio
-
Taylor Frigon Capital Management LLC425KShares$4.76 Million1.1% of portfolio
-
Cm Management, LLC375KShares$4.2 Million1.88% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $275M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...